AVITA Medical, Inc.
RCEL
$4.48
-$0.15-3.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.62M | -13.19M | -9.92M | -13.86M | -11.59M |
| Total Depreciation and Amortization | 647.00K | 574.00K | 552.00K | 521.00K | 409.00K |
| Total Amortization of Deferred Charges | 53.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.45M | 6.44M | 928.00K | 2.79M | 3.85M |
| Change in Net Operating Assets | 4.04M | 952.00K | -1.79M | 241.00K | -746.00K |
| Cash from Operations | -5.44M | -5.22M | -10.23M | -10.31M | -8.08M |
| Capital Expenditure | 674.00K | -934.00K | -524.00K | -221.00K | -1.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -663.00K | -4.41M | 7.54M | 10.99M | 4.08M |
| Cash from Investing | 11.00K | -5.34M | 7.02M | 10.77M | 2.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 248.00K | 14.82M | 559.00K | 363.00K | 1.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.06M | -- | -- | -- |
| Cash from Financing | 248.00K | 13.77M | 559.00K | 363.00K | 1.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.18M | 3.21M | -2.65M | 820.00K | -4.59M |